View Menu

RCCA is committed to providing our patients with access to the highest-quality, most-comprehensive, cutting edge treatments available, and to providing those treatments in a compassionate and community-based setting to maximize outcomes and the patient/caregiver experience.

RCCA is transforming healthcare by making all treatment information available to patients, their physicians and the full treatment team. Our passion for transparent patient care puts all clinical information in the hands of the team, giving them the ability to personalize treatment options and target therapies appropriately. These treatments are patient-focused, life-enriching and research-based to ensure that the best therapy is chosen for each patient. Please search our comprehensive resource center for more information…

RCCA is transforming healthcare by making all treatment information available to patients, their physicians and treatment team. Our passion for transparent patient care puts all clinical information in the hands of the team, giving them the ability to personalize treatment options and target therapies appropriately. These treatments are patient-focused, life-enriching and research-based to ensure that the best therapy is chosen for each patient.

Clinical Trials

A Phase 2 Study to Assess the Feasibility and Tolerance of the Combination of Elotuzumab, Lenalidomide, and Dexamethasone (ERd) in the Induction, Consolidation, and Maintenance Treatment of Transplant-Eligible Patients Newly Diagnosed with Multiple Myeloma (MM)